PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 57.00
+0.10 (0.18%)
Mar 24, 2026, 1:30 PM CST
PharmaEngine Revenue
In the year 2025, PharmaEngine had annual revenue of 911.42M TWD, down -63.88%. PharmaEngine had revenue of 285.09M in the quarter ending December 31, 2025, a decrease of -84.83%.
Revenue
911.42M
Revenue Growth
-63.88%
P/S Ratio
8.97
Revenue / Employee
20.71M
Employees
44
Market Cap
8.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 911.42M | -1.61B | -63.88% |
| Dec 31, 2024 | 2.52B | 1.76B | 228.70% |
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.37B |
| Savior Lifetec | 1.20B |
| Adimmune | 1.20B |
| Mycenax Biotech | 740.24M |
| TCM Biotech International | 685.49M |
| Tanvex BioPharma | 400.97M |
| TaiGen Biopharmaceuticals Holdings | 259.47M |
| Gongwin Biopharm Holdings | 36.45M |